항체 탐색 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for antibody discovery. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global antibody discovery market from 2025 to 2032.

Key Insights:

• Antibody Discovery Market Size (2025E): USD 8.80 Billion
• Projected Market Value (2032F): USD 16.2 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 9.0%

Antibody Discovery Market - Report Scope:

Antibody discovery plays a critical role in the development of targeted therapeutics for a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. The antibody discovery market caters to pharmaceutical and biotechnology companies, offering a range of techniques such as hybridoma, phage display, and B-cell screening, among others. Market growth is driven by increasing demand for monoclonal antibodies, advancements in discovery platforms, and a rise in global healthcare expenditures.

Market Growth Drivers:

The global antibody discovery market is propelled by several key factors, including the increasing prevalence of chronic diseases, rising cancer incidence, and the growing focus on personalized medicine. Technological advancements, such as the development of next-generation sequencing (NGS) and artificial intelligence (AI)-driven antibody discovery platforms, are significantly enhancing the efficiency and success rate of antibody development. Moreover, the rapid adoption of monoclonal antibodies in cancer therapies and autoimmune treatments, along with the expanding clinical pipeline, continues to drive market expansion.

Market Restraints:

Despite promising growth prospects, the antibody discovery market faces challenges related to the high cost of antibody development, lengthy approval timelines, and regulatory complexities. The high investment required for research and development, coupled with significant hurdles in ensuring clinical efficacy and safety, poses challenges for market penetration, especially for smaller players. Additionally, issues regarding antibody resistance and the limited availability of high-quality therapeutic targets hinder market potential.

Market Opportunities:

The antibody discovery market presents significant growth opportunities driven by technological innovations and expanding therapeutic applications. The integration of AI and machine learning technologies to improve antibody screening processes is expected to revolutionize the field, offering more precise and cost-effective solutions. Furthermore, the increasing focus on rare diseases, infectious disease outbreaks, and the development of biosimilars creates new avenues for antibody discovery companies. Strategic partnerships, investment in R&D, and the introduction of novel antibody discovery platforms are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the antibody discovery market globally?
• Which discovery techniques and applications are driving the adoption of antibody discovery technologies across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the antibody discovery market?
• Who are the key players contributing to the antibody discovery market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global antibody discovery market?

Competitive Intelligence and Business Strategy:

Leading players in the global antibody discovery market, including Thermo Fisher Scientific, Lonza Group, and Genmab, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced antibody discovery solutions, such as humanized antibodies, bispecific antibodies, and antibody-drug conjugates, catering to diverse therapeutic needs. Collaborations with pharmaceutical and biotech companies, medical research institutions, and regulatory bodies facilitate market access and promote technology adoption. Moreover, emphasis on clinical trials, evidence-based research, and patient-centered care continues to fuel growth and enhance the overall efficacy of antibody therapies.

Key Companies Profiled:

• Thermo Fisher Scientific
• Lonza Group
• Genmab
• Abbott Laboratories
• Bio-Rad Laboratories
• Adimab LLC
• WuXi AppTec
• Abcam PLC
• MedImmune, LLC
• Regeneron Pharmaceuticals, Inc.

Antibody Discovery Market Research Segmentation

By Method:

• Phage Display
• Hybridoma

By Antibody Type:

• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody

By End-use:

• Pharmaceutical and Biotechnology industry
• Research laboratory
• Academic laboratory

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Antibody Discovery Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Method Lifecycle Analysis
• 2.4. Antibody Discovery Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Antibody Discovery Market Outlook: Method
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Method, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
    • 3.3.3.1. Phage Display
    • 3.3.3.2. Hybridoma
    • 3.3.3.3. Others
• 3.4. Market Attractiveness Analysis: Method
• 3.5. Global Antibody Discovery Market Outlook: Antibody Type
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Antibody Type, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
    • 3.5.3.1. Humanized Antibody
    • 3.5.3.2. Human Antibody
    • 3.5.3.3. Chimeric Antibody
    • 3.5.3.4. Murine Antibody
• 3.6. Market Attractiveness Analysis: Antibody Type
• 3.7. Global Antibody Discovery Market Outlook: End User
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
  • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
    • 3.7.3.1. Pharmaceutical and Biotechnology industry
    • 3.7.3.2. Research laboratory
    • 3.7.3.3. Academic laboratory
• 3.8. Market Attractiveness Analysis: End User

4. Global Antibody Discovery Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia & Pacific
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Method
  • 5.3.3. By Antibody Type
  • 5.3.4. By End User
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 5.5.1. Phage Display
  • 5.5.2. Hybridoma
  • 5.5.3. Others
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 5.6.1. Humanized Antibody
  • 5.6.2. Human Antibody
  • 5.6.3. Chimeric Antibody
  • 5.6.4. Murine Antibody
• 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 5.7.1. Pharmaceutical and Biotechnology industry
  • 5.7.2. Research laboratory
  • 5.7.3. Academic laboratory
• 5.8. Market Attractiveness Analysis

6. Europe Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Method
  • 6.3.3. By Antibody Type
  • 6.3.4. By End User
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 6.5.1. Phage Display
  • 6.5.2. Hybridoma
  • 6.5.3. Others
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 6.6.1. Humanized Antibody
  • 6.6.2. Human Antibody
  • 6.6.3. Chimeric Antibody
  • 6.6.4. Murine Antibody
• 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 6.7.1. Pharmaceutical and Biotechnology industry
  • 6.7.2. Research laboratory
  • 6.7.3. Academic laboratory
• 6.8. Market Attractiveness Analysis

7. East Asia Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Method
  • 7.3.3. By Antibody Type
  • 7.3.4. By End User
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 7.5.1. Phage Display
  • 7.5.2. Hybridoma
  • 7.5.3. Others
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 7.6.1. Humanized Antibody
  • 7.6.2. Human Antibody
  • 7.6.3. Chimeric Antibody
  • 7.6.4. Murine Antibody
• 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 7.7.1. Pharmaceutical and Biotechnology industry
  • 7.7.2. Research laboratory
  • 7.7.3. Academic laboratory
• 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Method
  • 8.3.3. By Antibody Type
  • 8.3.4. By End User
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 8.5.1. Phage Display
  • 8.5.2. Hybridoma
  • 8.5.3. Others
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 8.6.1. Humanized Antibody
  • 8.6.2. Human Antibody
  • 8.6.3. Chimeric Antibody
  • 8.6.4. Murine Antibody
• 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 8.7.1. Pharmaceutical and Biotechnology industry
  • 8.7.2. Research laboratory
  • 8.7.3. Academic laboratory
• 8.8. Market Attractiveness Analysis

9. Latin America Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Method
  • 9.3.3. By Antibody Type
  • 9.3.4. By End User
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 9.5.1. Phage Display
  • 9.5.2. Hybridoma
  • 9.5.3. Others
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 9.6.1. Humanized Antibody
  • 9.6.2. Human Antibody
  • 9.6.3. Chimeric Antibody
  • 9.6.4. Murine Antibody
• 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 9.7.1. Pharmaceutical and Biotechnology industry
  • 9.7.2. Research laboratory
  • 9.7.3. Academic laboratory
• 9.8. Market Attractiveness Analysis

10. Middle East & Africa Antibody Discovery Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Method
  • 10.3.3. By Antibody Type
  • 10.3.4. By End User
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2025 - 2032
  • 10.5.1. Phage Display
  • 10.5.2. Hybridoma
  • 10.5.3. Others
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2025 - 2032
  • 10.6.1. Humanized Antibody
  • 10.6.2. Human Antibody
  • 10.6.3. Chimeric Antibody
  • 10.6.4. Murine Antibody
• 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2025 - 2032
  • 10.7.1. Pharmaceutical and Biotechnology industry
  • 10.7.2. Research laboratory
  • 10.7.3. Academic laboratory
• 10.8. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Hybridoma
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Alcami Corporation, Inc.
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. BASF SE
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Bioduro-Sundia
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Bruker
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Cambrex Corporation
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Croda International Plc
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Aragen Life Sciences Pvt. Ltd
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Eurofins DiscoverX Corporation
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. NanoCellect Biomedical
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Sartorius AG
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations